Vident Advisory’s Pediatrix Medical MD Stock Holding History

Vident Advisory's MD Position: Q2 2026 in Review

Vident Advisory reduced its Pediatrix Medical (MD) stake by 0.69% in Q2 2026, selling an estimated $6.08K and leaving 38,507 shares worth $975K. The position accounts for 0.01% of the portfolio, ranked #980.

Vident Advisory first reported a position in MD in Q4 2023 and has held it in 10 quarters since. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

• Vident Advisory held 38,507 shares of Pediatrix Medical worth $975K as of Q2 2026.
• Vident Advisory sold 267 Pediatrix Medical shares in Q2 2026, an estimated $6.08K.
• Pediatrix Medical made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #980 holding.
• Vident Advisory first reported a position in Pediatrix Medical in Q4 2023 and has held it in 10 quarters since.
• 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.